Experimental Ebola Vaccine Trial

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 30, 2003

Study Completion Date

August 22, 2007

Conditions

Hemorrhagic Fever, EbolaHealthy

Interventions

DRUG

VRC-EBODNA012-00-VP

Trial Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00072605 - Experimental Ebola Vaccine Trial | Biotech Hunter | Biotech Hunter